MicroRNA‐195‐5p Targets MYB to Regulate Proliferation and Malignant Metastasis in Triple‐Negative Breast Cancer via PI3K/AKT/mTOR Signaling
The Breast Journal · 2025-01 · 2025 (1)
DOI: 10.1155/tbj/7303173 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Breast Journal, online erschienen am 16.10.2025. Verfasst von Kewei Tang und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Yueyang Central Hospital, Yueyang, Hunan, China. Hauptthemen laut MEDLINE: Triple Negative Breast Neoplasms, MicroRNAs, Proto-Oncogene Proteins c-myb. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To investigate the effect of microRNA‐195‐5p (miRNA‐195‐5p) on proliferation and malignant metastasis in triple‐negative breast cancer (TNBC) cells and its underlying mechanism.
Methods
Expression levels of miRNA‐195‐5p and MYB were determined by quantitative real‐time PCR (RT‐qPCR) in TNBC cells (MDA‐MB‐231 and BT‐549) and normal human mammary epithelial cells (MCF‐10A). Cell proliferation was assessed via CCK‐8 assays after miRNA‐195‐5p overexpression or knockdown in MDA‐MB‐231 cells. Transwell assays evaluated cellular invasion and migration. Western blotting analyzed impacts on the PI3K/AKT/mTOR pathway. Targeting of MYB by miRNA‐195‐5p was confirmed using TargetScan prediction and dual‐luciferase reporter assays. RT‐qPCR measured MYB expression upon miRNA‐195‐5p modulation. Rescue experiments (co‐overexpression of MYB and miRNA‐195‐5p) further assessed proliferation and PI3K/AKT/mTOR signaling via CCK‐8 and Western blotting.
Results
Compared to MCF‐10A cells, miRNA‐195‐5p expression was significantly downregulated ( p < 0.01), while MYB was markedly upregulated ( p < 0.001) in TNBC cells. Overexpression of miRNA‐195‐5p inhibited MDA‐MB‐231 proliferation, invasion, and migration; conversely, its knockdown promoted these phenotypes. MiRNA‐195‐5p directly targeted and negatively regulated MYB. MYB overexpression activated the PI3K/AKT/mTOR pathway, enhancing cell proliferation. Rescue experiments indicated that MYB upregulation counteracted the tumor‐suppressive effects of miRNA‐195‐5p and reactivated PI3K/AKT/mTOR signaling. Conclusion miRNA‐195‐5p suppresses proliferation and metastasis in TNBC by targeting MYB and inhibiting the PI3K/AKT/mTOR pathway.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Yueyang Central Hospital, Yueyang, Hunan, China.
ORCID-Profile: Kewei Tang, Site Bai, Qiang Zhou, Songlian Liu, Leilan Yin, Yajun Tong, Ling Long, Ludi Ou, Qinghua Yin
Zitieren
APA
Tang, K., Bai, S., Zhou, Q., Liu, S., Yin, L., Tong, Y., Long, L., Ou, L., & Yin, Q. (2025). MicroRNA‐195‐5p Targets MYB to Regulate Proliferation and Malignant Metastasis in Triple‐Negative Breast Cancer via PI3K/AKT/mTOR Signaling. The Breast Journal, 2025(1). https://doi.org/10.1155/tbj/7303173
Vancouver
Tang K, Bai S, Zhou Q, Liu S, Yin L, Tong Y, et al. MicroRNA‐195‐5p Targets MYB to Regulate Proliferation and Malignant Metastasis in Triple‐Negative Breast Cancer via PI3K/AKT/mTOR Signaling. The Breast Journal. 2025;2025(1). doi:10.1155/tbj/7303173
BibTeX
@article{Tang2025,
author = {Tang, Kewei and Bai, Site and Zhou, Qiang and Liu, Songlian and Yin, Leilan and Tong, Yajun and Long, Ling and Ou, Ludi and Yin, Qinghua},
title = {MicroRNA‐195‐5p Targets MYB to Regulate Proliferation and Malignant Metastasis in Triple‐Negative Breast Cancer via PI3K/AKT/mTOR Signaling},
journal = {The Breast Journal},
year = {2025},
volume = {2025},
number = {1},
doi = {10.1155/tbj/7303173}
}
EUVIMED